CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 64 enrolled
Drug / intervention
Betablockers or other preventive drugs based on primary headache typedrug
Likely dose
Not stated in record
Key inclusion· 1
  • Probable medication-overuse headache according to ICHD-2 criteria (section 8.2.7)
Key exclusion· 8
  • No benefit from all available preventive medications
  • No benefit from abrupt withdrawal of overused acute medication lasting more than 3 weeks
  • Cluster headache
  • Chronic paroxysmal hemicrania

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00159588
NCT00159588N/ACompleted

Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly? A Randomized Multi-centre Follow-up.

Norwegian University of Science and Technology·interventional·Posted Sep 12, 2005·Updated Mar 11, 2022

In Brief

A clinical study evaluating Betablockers or other preventive drugs based on primary headache type for Headache. Completed, enrolled 64 participants across 1 site.

Detailed Summary

It is a common belief that patients with MOH rarely respond of preventative medications whilst overusing acute medications. However, no randomized trial has been done previously to prove such statement. Based on some clinical experiences, our hypothesis are patients with probably MOH may benefit from use of preventive medications better than treatment with abrupt withdrawal or no specific treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeadache
CountriesNorway
Collaborators--

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 12, 2005
Enrollment StartJan 1, 2004
Primary CompletionNov 1, 2006
Study CompletionDec 1, 2007
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 20.8 years ago

Interventions

Betablockers or other preventive drugs based on primary headache typedrug

Several preventive drugs based on each individual regarding type of original headache type (i.e angiotensin II blockers, betablockers, valproate, tricyclic antidepressants or gabapentin)